Oral Session 2-9A MM: Global clinical trials

[OS2-9A-5] A systematic literature review and network meta-analysis of regimens for transplant-ineligible NDMM

Annette Lam¹, Thierry Facon², Meletios A. Dimopoulos³, Maria-Victoria Mateos⁴, Michele Cavo⁵, Bart Heeg⁶, Sophie van Beekhuizen⁶, Marta Pisini⁷, Sandhya Nair⁸, Mary Slavcev¹, Jesus San-Miguel⁹ (1.Janssen Global Services, Raritan, United States of America, 2.Hopital Claude Huriez, CHRU Lille, Lille, France Metropolitan, 3.National and Kapodistrian University of Athens, Athens, Hellenic Republic, 4.University Hospital of Salamanca/IBSAL, Salamanca, Spain, 5.“Seragnoli” Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italian Republic, 6.Ingress Health, Rotterdam, Kingdom of the Netherlands, 7.Janssen EMEA, Kingdom of Belgium, 8.Janssen Research and Development, Beerse, Kingdom of Belgium, 9.Clinica Universidad de Navarra-CIMA, IDISNA, CIBERONC, Pamplona, Spain)